logo
Salud por Derecho
Eng
  • Esp
  • Eng
logo
  • ABOUT US
  • WHAT WE DO
  • COLLABORATE
  • NEWS
Imagen destacada
Uncategorized
US$18 Billion to save 20 million lives
01/03/2022 by Salud in Uncategorized

The Global Fund’s Investment Case explains the need for US$18 billion to get back on track to end AIDS, TB and malaria, accelerate progress toward the Sustainable Development Goal (SDG) 3 of “health and well-being for all” and universal health coverage, and strengthen pandemic preparedness.

In the 20 years since the Global Fund was created, the partnership has saved 44 million lives and cut the death toll from the three diseases by 40%. But the Global Fund’s Results Report revealed significant progress has been lost because of the COVID-19 pandemic and global resource needs have increased. This is why the Global Fund funding needs are higher than in 2019 for the Sixth Replenishment.

“In the face of the catastrophic impact of COVID-19 on the fight against HIV, TB and malaria, the choice is stark: We either increase funding, or we abandon hope of finally defeating these epidemics by 2030,” said Peter Sands, Executive Director of the Global Fund. “We must increase support to countries to build more resilient, sustainable and inclusive systems for health. This is crucial for ending HIV, TB and malaria, defeating COVID-19 and protecting people from future infectious disease threats around the world.”

A successful Replenishment would allow the partnership to:

  • Save 20 million lives between 2024 and 2026, reducing the mortality rate by 64% across the three diseases by 2026, relative to 2020 levels.
  • Avert more than 450 million infections or cases, reducing the incidence rate by 58% across the three diseases by 2026, relative to 2020 levels.
  • Reduce the death toll across the three diseases to 950,000 in 2026, down from 2.4 million in 2020, and from 4 million in 2005.
  • Catalyze the scale-up of domestic investments of up to US$59 billion toward ending the three diseases and strengthening systems for health through co-financing requirements and technical assistance on health financing.
  • Reinforce systems for health and pandemic preparedness by investing approximately US$6 billion to support health care workers; strengthen laboratories, diagnostic tools, supply chain management, information and financial systems; tackle antimicrobial resistance, including drug-resistant TB; reinforce community systems; and accelerate the shift toward patient-centered, differentiated models of care.
  • Yield a return on investment of 1:31 with every dollar invested in fighting the three diseases resulting in US$31 in health gains and economic returns, further contributing to the achievement of the overall SDG agenda.

“When the Global Fund was created 20 years ago, HIV, TB and malaria seemed unbeatable,” said Lady Roslyn Morauta, Vice-Chair of the Global Fund Board. “But we have proven that with science, adequate resources and effective global and local collaboration, we can force even the deadliest diseases into retreat. Ahead of the Global Fund’s Seventh Replenishment, and less than a decade to the United Nations Sustainable Development Goals, we call the entire partnership to mobilize to increase financial resources to fight and defeat the three diseases”.

Compartir:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
Linkedin
Share on email
Email
Share on whatsapp
Whatsapp
Salud

Search

Subscribe to Newsletter

Estoy de acuerdo con la Política de privacidad.

LOCATION

Salud por Derecho
Duque Fernán Núñez, 2.
28012 Madrid
saludporderecho@saludporderecho.org

facebook twitter youtube

ABOUT US

About us

What we do

Collaborate

News

Privacy Policy

Cookie Policy

Publications

Press Area

SUBSCRIBE TO OUR NEWSLETTER

Estoy de acuerdo con la Política de privacidad.

Compartir:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
Linkedin
Share on email
Email
Share on whatsapp
Whatsapp
logo
Política de Cookies
Esta web utiliza cookies propias y de terceros para analizar tu navegación y ofrecerte un servicio más personalizado acorde a tus intereses. Continuar navegando implica la aceptación de nuestra Política de Cookies. También hemos actualizado nuestra Política de Privacidad para adecuarnos a la nueva normativa europea, puedes consultarla en la web. Aceptar Rechazar
Política de Cookies

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT